HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.

AbstractBACKGROUND & AIMS:
Mosaic G-protein alpha-subunit (GNAS)-activating mutations are responsible for the McCune-Albright (MCA) syndrome. This oncogene that activates the adenylate cyclase is also mutated in various tumor types leading to the accumulation of cyclic-AMP. Identification of a hepatocellular adenoma (HCA) in two MCA patients led us to search for GNAS activation in benign and malignant hepatocellular carcinogenesis.
METHODS:
GNAS mutations were screened by sequencing 164 HCA, 245 hepatocellular carcinoma (HCC), and 17 fibrolamellar carcinomas. Tumors were characterized by quantitative RT-PCR, gene mutation screening and pathological reviewing. The consequences of wild type and mutant GNAS expression were analyzed in hepatocellular cell lines.
RESULTS:
A somatic GNAS-activating mutation was identified in 5 benign tumors and in 2 HCC. In benign tumors, GNAS mutations were exclusive from HNF1A, CTNNB1, and IL6ST mutations whereas one HCC demonstrated both CTNNB1 and GNAS mutations. Quantitative RT-PCR showed an activation of the IL-6 and interferon pathways in GNAS-mutated tumor tissues. Accordingly, pathological reviewing identified in GNAS-mutated tumors an inflammatory phenotype characterized by fibrosis and STAT3 activation. We further demonstrated in HCC cell lines that GNAS mutant expression induced inflammatory response and STAT3 activation.
CONCLUSIONS:
We identified for the first time the association between two rare diseases, MCA syndrome and HCA occurrence, but also that somatic GNAS-activating mutations in sporadic benign and malignant liver tumors are characterized by an inflammatory phenotype. These results showed a cross-talk between cyclic-AMP and JAK/STAT pathways in liver tumors and they reinforce the role of STAT3 activation in liver tumorigenesis.
AuthorsJean Charles Nault, Monique Fabre, Gabrielle Couchy, Camilla Pilati, Emmanuelle Jeannot, Jeanne Tran Van Nhieu, Marie-Christine Saint-Paul, Anne De Muret, Marie-José Redon, Catherine Buffet, Sylvie Salenave, Charles Balabaud, Sophie Prevot, Philippe Labrune, Paulette Bioulac-Sage, Jean-Yves Scoazec, Philippe Chanson, Jessica Zucman-Rossi
JournalJournal of hepatology (J Hepatol) Vol. 56 Issue 1 Pg. 184-91 (Jan 2012) ISSN: 1600-0641 [Electronic] England
PMID21835143 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Chemical References
  • DNA, Neoplasm
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • GNAS protein, human
  • GTP-Binding Protein alpha Subunits, Gs
Topics
  • Adenoma, Liver Cell (genetics, metabolism, pathology)
  • Adult
  • Aged
  • Base Sequence
  • Carcinoma, Hepatocellular (genetics, metabolism, pathology)
  • DNA Mutational Analysis
  • DNA, Neoplasm (genetics)
  • Female
  • Fibrous Dysplasia, Polyostotic (genetics)
  • GTP-Binding Protein alpha Subunits, Gs (genetics)
  • Humans
  • Liver Neoplasms (classification, genetics, metabolism, pathology)
  • Male
  • Middle Aged
  • Models, Biological
  • Mutation
  • STAT3 Transcription Factor (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: